Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D06ERY
|
||||
| Former ID |
DNCL001731
|
||||
| Drug Name |
BMS-394136
|
||||
| Indication | Arrhythmia [ICD9: 427; ICD10:I47-I49] | Phase 1 | [1] | ||
| Company |
Bristol-Myers Squibb
|
||||
| Target and Pathway | |||||
| Target(s) | Potassium voltage-gated channel subfamily A member 5 | Target Info | Modulator | [2] | |
| PathWhiz Pathway | Muscle/Heart Contraction | ||||
| Reactome | Voltage gated Potassium channels | ||||
| WikiPathways | Potassium Channels | ||||
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT00162448) A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators. U.S. National Institutes of Health. | ||||
| REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.